InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by SALZMAN BARRY M, Director. Officer active across 1 company, notably Checkpoint Therapeutics, Inc.. Cumulatively, 7 reports have been logged. History available since 10 June 2021. The latest transaction was filed on 28 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Barry M. Salzman is a Board Member at Checkpoint Therapeutics, Inc. He has significant experience in corporate governance and business strategy. Barry plays a key role in guiding board decisions and implementing best practices within the company.